# Northrop Grumman Q3 Preview: Bad News Priced In

> Northrop Grumman stock near 52-week lows despite strong Q2 results and record backlog.
- Title: Northrop Grumman Q3 Preview: Bad News Priced In · Seekingalpha
- Summary: Northrop Grumman stock near 52-week lows despite strong Q2 results and record backlog. Northrop Grumman's Q3 results expected to show margin pressures but…
- Keywords: northrop grumman, defense, backlog, sentinel, b-21, q3 earnings, margin pressures, valuation, dividend, money, business, Northrop
- Source: Seekingalpha — https://seekingalpha.com/article/4953861-northrop-grumman-q3-preview-bad-news-priced-in-defense-buy
- Author: Julia Ostian
- Published: 2026-10-13T16:57:43+00:00
- Read time: 1 min
- Topics: northrop grumman, q3, defense, backlog, sentinel, b-21, q3 earnings, margin pressures, valuation, dividend, money, business
## Northrop Grumman Q3 Preview
Northrop Grumman trades near 52-week lows despite record backlog, raised guidance, and accelerating key programs like B-21 and Sentinel.
## Q2 Results Show Strength
NOC's Q2 results showed strong sales and backlog growth, but margin pressures from program charges and timing risks around government funding persist.
## Attractive Entry Point
Valuation at 16.8x 2026 EPS guidance presents an attractive entry, with a 2% dividend yield and low expectations ahead of Q3 earnings.
## Investment Strategy
I favor starting a position before results, keeping dry powder for post-earnings volatility if margin or cash flow disappointments drive further downside.
## Key takeaway

Northrop Grumman's Q3 results expected to show margin pressures but valuation at 16.8x 2026 EPS guidance makes it a defensive buy.